Tag: Bristol-Myers Squibb
Syngene International to acquire stake in O2 Renewable Energy II
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
USFDA approves expanded use of Bristol Myers immunotherapy for cancer
The approval marks the first-and-only immunotherapy-based treatment for use before surgery for non-small cell lung cancer
QuintilesIMS led alliance to generate insights on usage of anti-cancer therapies
QuintilesIMS has formed new collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to addresses information gaps on actual utilization of anti-cancer therapies....